Clinical Intelligence API
Drug data API
Company describes it as enhancing healthcare software with "evidence-based and structured drug information", including a drug interaction checker and advanced drug search features.
Learn more
DrugBank
Biotechnology & Life SciencesAIEdmonton, AB
Edmonton company, operating as OMx Personal Health Analytics Inc., that curates and licenses structured biomedical drug data — a drug, target and trial knowledge graph delivered through commercial data packages, a clinical API and an MCP endpoint for customers' AI tools.
Canadian innovation builds a brighter tomorrow.
About
Company site: drugbank.comEdmonton company, operating as OMx Personal Health Analytics Inc., that curates and licenses structured biomedical drug data — a drug, target and trial knowledge graph delivered through commercial data packages, a clinical API and an MCP endpoint for customers' AI tools.
Operates as OMx Personal Health Analytics Inc., federal corporation 826702-2, incorporated under the CBCA on 2012-08-03, status Active. ised-isde.canada.ca
States DrugBank began at the University of Alberta, where co-founders Craig Knox and Michael Wilson helped create a database of 4,000 drugs and their biological targets. drugbank.com
Raised a $9M seed round announced April 2022, led by Brightspark Ventures with Amplitude Ventures, Theodorus Investment Funds, AccelerateFund and BoxOne Ventures, which led the earlier pre-seed. blog.drugbank.com
Lists Alberta Innovates, Genome Alberta, Genome Canada and the NRC among its funders alongside venture investors. No dollar amounts are published for any of them. drugbank.com
Products & Services
Company site: drugbank.comProducts DrugBank publishes on its own site. Each card links to the page it was taken from.
DrugBank MCP
AI integration endpoint
Company describes it as letting AI tools connect directly to DrugBank's structured knowledge graph over the Model Context Protocol, so responses are grounded in its knowledgebase rather than general training data.
Learn moreFunding & Investors
Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
Seed
Apr 11, 2022
C$9.0Mblog.drugbank.comInvestors: Brightspark Ventures, Amplitude Ventures, Theodorus Investment Funds, AccelerateFund, BoxOne Ventures
Total disclosed: C$9.0MLatest: Seed · Apr 11, 2022
Recent News
- Aug 17, 2026Product
Summer 2026 product roundup
DrugBank reported densifying its knowledge graph with new entry points including chemical-structure and protein-sequence search, deeper target biology and structured trial detail, exposed through its MCP endpoint.
- Oct 21, 2025Leadership
DrugBank announces leadership transition
DrugBank announced that Lisa Downey had been appointed chief executive effective October 6, 2025, with co-founder Mike Wilson moving from chief executive to chief product officer.
People
Sourced from the company's own pages or announcements.
Lisa Downey
Chief Executive Officer
Mike Wilson
Chief Product Officer and Co-founder
Craig Knox
Chief Technology Officer and Co-founder
Technology Focus
Company site: drugbank.comTerms the company uses about its own work.
Biomedical knowledge graphDrug data licensingClinical API
Similar Companies
Other companies in Biotechnology & Life Sciences.
